In September, the virtual grand rounds of the Washington State Medical Association featured Lisa A. Jackson, MD, MPH, Kaiser Permanente Washington Health Research Institute (KPWHRI) senior investigator and Washington Permanente Medical Group (WPMG) physician. Dr. Jackson spoke on “COVID-19 vaccines: Clinical trials and the response plans.” Principal investigator for KPWHRI’s Vaccine & Treatment Evaluation Unit, she is senior author on the latest publication in the New England Journal of Medicine about a clinical trial for an investigational mRNA vaccine to prevent infection by the SARS-CoV-2 virus that causes COVID-19.
The first Kaiser Permanente Bernard J. Tyson School of Medicine Research Faculty Interest Group, Health Systems Science Department, featured Michael L. Parchman, MD, MPH. Dr. Parchman is a senior investigator at the KPWHRI MacColl Center for Health Care Innovation and was interviewed for a discussion on quality improvement and implementation science. Also interviewed was Brian S. Mittman, PhD, from the Kaiser Permanente Southern California Department of Research & Evaluation.
Puget Sound Business Journal included KPWHRI Adjunct Researcher and WPMG physician Annie Hoopes, MD, MPH on its “40 Under 40” list (subscription required). Dr. Hoopes specializes in treating teens with intersecting medical and mental health needs. Her work with KPWHRI includes consulting on a Learning Health System project to design and implement universal screening for adolescent depression and substance use in primary care.
A recent Editor’s Choice collection of papers on suicide prevention in Psychiatric Services featured several by KPWHRI Research Associate Julie Richards, PhD, MPH and Senior Investigator Gregory E. Simon, MD, MPH. The collection focused on studies in the theme of “identifying and predicting risk, vulnerable populations, public perceptions, and priority settings” and contained papers by other authors who are part of the Mental Health Research Network.